Galantamine

Galantamine is a reversible, competitive acetylcholinesterase inhibitor and allosteric potentiating ligand of nicotinic receptors used for the symptomatic treatment of mild-to-moderate Alzheimer's disease and dementia. It enhances cholinergic neurotransmission in the brain.

Mediocon Inc supplies Galantamine IP/BP/USP as a pharmaceutical-grade active ingredient for manufacturers producing anti-dementia and cognitive health formulations. Our GMP-certified manufacturing ensures batch-to-batch consistency and full regulatory compliance.

Key Features

• Dual-mechanism AChE inhibitor
• Allosteric potentiating ligand (APL)
• For mild-to-moderate Alzheimer's therapy
• Meets IP/BP/USP pharmacopoeial standards

Applications

• Alzheimer's disease symptom management
• Vascular dementia formulations
• Cognitive enhancement neurological products
• Geriatric pharmaceutical manufacturing

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings